Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy.

MLA

Ninčević, Vjera, et al. “Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy.” Current Issues in Molecular Biology, vol. 44, no. 3, Feb. 2022, pp. 1087–114. EBSCOhost, https://doi.org/10.3390/cimb44030072.

APA

Ninčević, V., Zjalić, M., Kolarić, T. O., Smolić, M., Kizivat, T., Kuna, L., Včev, A., Tabll, A., & Ćurčić, I. B. (2022). Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy. Current Issues in Molecular Biology, 44(3), 1087–1114. https://doi.org/10.3390/cimb44030072

Chicago

Ninčević, Vjera, Milorad Zjalić, Tea Omanović Kolarić, Martina Smolić, Tomislav Kizivat, Lucija Kuna, Aleksandar Včev, Ashraf Tabll, and Ines Bilić Ćurčić. 2022. “Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy.” Current Issues in Molecular Biology 44 (3): 1087–1114. doi:10.3390/cimb44030072.